Literature DB >> 16702533

Anterior septal reconstruction: outcomes after a modified extracorporeal septoplasty technique.

Sam P Most1.   

Abstract

OBJECTIVE: To describe a modified extracorporeal septoplasty technique and measure its efficacy with a validated quality-of-life instrument.
DESIGN: A prospective observational outcomes study of patients with severe septal deviation who subsequently underwent anterior septal reconstruction. Preoperative and postoperative evaluation was performed using photographs and the Nasal Obstruction Symptoms Evaluation scale.
RESULTS: Twelve consecutive patients were enrolled. No complications occurred. All patients noted improved airway function postoperatively. There was a significant improvement in mean Nasal Obstruction Symptoms Evaluation score postoperatively (76.6 vs 12.9; P<.01). Examination of postoperative photographs revealed improved midvault and tip anatomy.
CONCLUSIONS: The anterior septal reconstruction technique is effective in improving both nasal airway function and aesthetics in patients with severe septonasal deviation. The technique avoids the most common complication of standard extracorporeal septoplasty by preserving the dorsal strut of septal cartilage and its attachment to the nasal bones at the keystone area.

Entities:  

Mesh:

Year:  2006        PMID: 16702533     DOI: 10.1001/archfaci.8.3.202

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  16 in total

1.  Severe deviated nose treatment: importance of preserving the dorsal septal remnant.

Authors:  Amir A Sazgar; Yeganeh Teimouri; Sara Arjang; Amin Amali; Sam P Most
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-02       Impact factor: 2.503

2.  Straightening the Crooked Middle Vault With the Clocking Stitch: An Anatomic Study.

Authors:  Jarrod A Keeler; Sami P Moubayed; Sam P Most
Journal:  JAMA Facial Plast Surg       Date:  2017-05-01       Impact factor: 4.611

3.  Augmenting the nasal airway: beyond septoplasty.

Authors:  Patrick Simon; Douglas Sidle
Journal:  Am J Rhinol Allergy       Date:  2012 Jul-Aug       Impact factor: 2.467

Review 4.  A systematic review of patient-reported nasal obstruction scores: defining normative and symptomatic ranges in surgical patients.

Authors:  John S Rhee; Corbin D Sullivan; Dennis O Frank; Julia S Kimbell; Guilherme J M Garcia
Journal:  JAMA Facial Plast Surg       Date:  2014 May-Jun       Impact factor: 4.611

5.  Efficacy and Safety of Titanium Miniplates for Patients Undergoing Septorhinoplasty.

Authors:  Paul A Mittermiller; Clifford C Sheckter; Sam P Most
Journal:  JAMA Facial Plast Surg       Date:  2018-01-01       Impact factor: 4.611

6.  The Role of Extracorporeal Septoplasty in Severely Deviated Nasal Septum.

Authors:  Brajendra Baser; D K Patel; A Mishra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-11-28

7.  Three Dimensional Rhinoplasty and Nasal Airway Improvement in Cleft-Nose Deformity.

Authors:  John Oommen; Hafiz Muhammed Koyappathody; Kader Kalathingal; Chandrabose Vellani Thamunni; Subin Joseph; Srivatsa M Shet; Rajesh Vardhan Pydi; Anand Sivadasan; Santhy Mohanachandran Nair; Srikant Aruna Samantaray; R S Nithin; Joe Antony
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-06-19

8.  Outcomes of Extracorporeal Septoplasty and Its Modifications in Treatment of Severe L-Strut Septal Deviation: A Systematic Review and Meta-analysis.

Authors:  Emily A Spataro; Mikhail Saltychev; Cherian K Kandathil; Sam P Most
Journal:  JAMA Facial Plast Surg       Date:  2019-12-01       Impact factor: 4.611

9.  Technical Refinements and Outcomes of the Modified Anterior Septal Transplant.

Authors:  Myriam Loyo; Jeffrey D Markey; Deniz Gerecci; Edward El Rassi; Ryan J Li; C Blake Sullivan; Tom D Wang
Journal:  JAMA Facial Plast Surg       Date:  2018-01-01       Impact factor: 4.611

10.  Long-term Outcomes of Subtotal Septal Reconstruction in Rhinoplasty.

Authors:  Scott A Asher; Akta S Kakodkar; Dean M Toriumi
Journal:  JAMA Facial Plast Surg       Date:  2018-01-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.